ABAbdalla Bani

Abdalla Bani

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Abdalla Bani has a total of 34 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Taming dimensionality in big neuroimaging data: Efficient orthonormal projective NMF via stochastic learning and data compression

    by Abdalla Bani, Sung Min Ha, Thomas Earnest, Braden Yang, Pan Xiao, John Lee, Janine Bijsterbosch, Aristeidis Sotiras

    Large-scale neuroimaging datasets present remarkable opportunities for advancing our understanding of human brain structure and function. Data-driven pattern analysis methods such as Orthonormal Projective Non-negative Matrix Factorization (opNMF) are particularly well suited to uncover multivariate relationships within these data, offering greater interpretability and reproducibility than more conventional approaches such as principal component analysis (PCA) and independent component analysis (ICA). Despite its utility in clinical computational neuroscience, the application of opNMF in large cohort studies has been impeded by computational challenges and scalability limitations. In this work, we address these issues by introducing a stochastic optimization strategy that processes mini-batches of the data, substantially improving scalability. We further accelerate computation through random data compression and leverage repulsive point processes to diversify mini-batches, reducing redundancy and the variance of updates. We first evaluated our method on gray matter tissue density maps from 1,000 participants in the Open Access Series of Imaging Studies (OASIS). Compared with the original approach, it achieved similar approximation accuracy and factor interpretability while greatly reducing computational cost. To demonstrate practical utility, we then applied the framework to 10,000 participants from the UK Biobank, identifying 20 patterns of structural covariance (PSCs) and examined associations between visceral adipose tissue (VAT) and PSC loadings, finding significant relationships for 13 PSCs in females and 11 PSCs in males, most of which were negative. We further show how these patterns refine in higher-rank decompositions with 40 and 60 components. This enhanced opNMF framework opens new possibilities for large-scale neuroimaging analyses, facilitating deeper insights into brain structure in both health and disease.

  • Open Access

    A unified model for staging amyloid and tau pathology in Alzheimer’s disease

    by Tom W. Earnest, Braden Y. Yang, Ahmad Chowdhury, Sung Min Ha, Abdalla Bani, Soo-Jong Kim, Arash Nazeri, John C. Morris, Tammie L. S. Benzinger, Brian A. Gordon, et al.

    Biological staging models are a key tool for assessing the severity of Alzheimer’s disease (AD), supporting personalized medicine and playing a critical role in clinical trial design. Recently, researchers have leveraged positron emission tomography (PET) to inform data-driven staging models of brain pathology related to AD. However, most approaches have focused on staging either amyloid or tau progressions separately, while both pathologies constitute defining factors of AD. Here, we aimed to derive a data-driven staging model which encompasses the spatial spread of both amyloid and tau. We assembled a large sample (n=3,293) of individuals with both amyloid and tau PET imaging stemming from 8 neuroimaging studies of AD and aging. We applied unsupervised machine learning to estimate brain areas which showed coordinated pathological accumulation across our sample, and we used these regions to inform a data-driven model for staging amyloid and tau. The resulting six stage model showed two stages of amyloid progression followed by four stages of tau spread, which were associated with cross-sectional and longitudinal assessments of cognitive decline. Comparison of our biological staging model with clinical disease stages recommended by the Alzheimer’s Association showed evidence of heterogenous symptom profiles. Replication of results in holdout data demonstrated the generalizability and prognostic value of our staging model. Together, these findings establish a comprehensive and rigorously validated biological staging model that jointly characterizes amyloid and tau progression, advances beyond global or anatomically predefined summaries, and provides a scalable framework for studying disease heterogeneity and progression in AD. One Sentence Summary: Using PET imaging from a large sample of individuals (n=3,293), we derive a data-driven model for staging amyloid and tau pathology.

  • Large-Scale Evaluation of Machine Learning Models in Identifying Follow-Up Recommendations in Radiology Reports

    by Pan Xiao, Xiaobing Yu, Sung Min Ha, Abdalla Bani, Aaron Mintz, Jieqi Wang, Mohamed Elbanan, Mahati Mokkarala, Govind Mattay, Arash Nazeri, et al.

    Machine learning models show promise for automating classification of follow-up recommendations in radiology reports across multiple imaging modalities.


  • Open Access

    Multimodal normative modeling in Alzheimer’s Disease with introspective variational autoencoders

    by Sayantan Kumar, Peijie Qiu, Braden Yang, Abdalla Bani, Philip R.O Payne, Aristeidis Sotiras

    Normative models in neuroimaging learn patterns of healthy brain distributions to identify deviations in disease subjects, such as those with Alzheimer’s Disease (AD). This study addresses two key limitations of variational autoencoder (VAE)-based normative models: (1) VAEs often struggle to accurately model healthy control distributions, resulting in high reconstruction errors and false positives, and (2) traditional multimodal aggregation methods, like Product-of-Experts (PoE) and Mixture-of-Experts (MoE), can produce uninformative latent representations. To overcome these challenges, we developed a multimodal introspective VAE that enhances normative modeling by achieving more precise representations of healthy anatomy in both the latent space and reconstructions. Additionally, we implemented a Mixture-of-Product-of-Experts (MOPOE) approach, leveraging the strengths of PoE and MoE to efficiently aggregate multimodal information and improve abnormality detection in the latent space. Using multimodal neuroimaging biomarkers from the Alzheimer’s Disease Neuroimaging Initiative (ADNI) dataset, our proposed multimodal introspective VAE demonstrated superior reconstruction of healthy controls and outperformed baseline methods in detecting outliers. Deviations calculated in the aggregated latent space effectively integrated complementary information from multiple modalities, leading to higher likelihood ratios. The model exhibited strong performance in Out-of-Distribution (OOD) detection, achieving clear separation between control and disease cohorts. Additionally, Z-score deviations in specific latent dimensions were mapped to feature-space abnormalities, enabling interpretable identification of brain regions associated with AD pathology.


  • Open Access

    Data‐driven decomposition and staging of flortaucipir uptake in Alzheimer's disease

    by Tom Earnest, Abdalla Bani, Sung Min Ha, Diana A. Hobbs, Deydeep Kothapalli, Braden Yang, John J. Lee, Tammie L. S. Benzinger, Brian A. Gordon, Aristeidis Sotiras, et al.

    INTRODUCTION: Previous approaches pursuing in vivo staging of tau pathology in Alzheimer's disease (AD) have typically relied on neuropathologically defined criteria. In using predefined systems, these studies may miss spatial deposition patterns which are informative of disease progression.METHODS: We selected discovery (n = 418) and replication (n = 132) cohorts with flortaucipir imaging. Non‐negative matrix factorization (NMF) was applied to learn tau covariance patterns and develop a tau staging system. Flortaucipir components were also validated by comparison with amyloid burden, gray matter loss, and the expression of AD‐related genes.RESULTS: We found eight flortaucipir covariance patterns which were reproducible and overlapped with relevant gene expression maps. Tau stages were associated with AD severity as indexed by dementia status and neuropsychological performance. Comparisons of flortaucipir uptake with amyloid and atrophy also supported our model of tau progression.DISCUSSION: Data‐driven decomposition of flortaucipir uptake provides a novel framework for tau staging which complements existing systems.Highlights: NMF reveals patterns of tau deposition in AD. Data‐driven staging of flortaucipir tracks AD severity. Learned flortaucipir patterns overlap with AD‐related gene expression.